Lifesaving drugs caught up in ‘funding logjam’

Lifesaving drugs have been caught up in a funding logjam as the HSE fears the cost involved could adversely affect existing services.

Lifesaving drugs caught up in ‘funding logjam’
Fri, 28 Jul, 2017 - 01:00
Evelyn Ring

Nine new hi-tech drugs were recommended for approval by the HSE, subject to additional funding being provided.

The drugs include new treatments for cancer and heart conditions. The HSE confirmed the cost over five years would be around €117m.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

MOTOR VEHICLE ACCIDENT; M50; JUNCTION 12 M50; KNOCKLYON FIRHOUSE Eight youths from one vehicle hospitalised and man injured after head-on M50 crash
Friedrich Merz visit to Ireland Budget 2027 will 'reduce cost for families', says Taoiseach
Over 40 items recalled from Dunnes and SuperValu over salmonella risk Over 40 items recalled from Dunnes and SuperValu over salmonella risk
CourtsDrugsFundingHSECostPlace: South Tipperary General HospitalPlace: IrelandPlace: EuropePerson: Minister for HealthPerson: Simon HarrisPerson: Alan KellyPerson: EntrestoPerson: Niall ColwellPerson: ColwellPerson: Oliver O’ConnorPerson: O’ConnorOrganisation: HSEOrganisation: Department of HealthOrganisation: Labour PartyOrganisation: RTÉ RadioOrganisation: Irish Pharmaceutical Healthcare AssociationOrganisation: IPHA
<p>Daniel Kinahan</p>

Breaking: Convoy carrying Daniel Kinahan arrives at Special Criminal Court

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited